Atlas Trials

Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients

Clinical trial NCT03271879 · UNKNOWN

Trial details

NCT number
NCT03271879
Sponsor
Rambam Health Care Campus
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart FailureDiabetes MellitusArrythmia
Start date
2018-02-15
Primary completion
2019-09-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.